China NMPA Approves Phase III Clinical Trial of ASC40 Combined with Bevacizumab for …,

(HKEX code: 1672) today announces that China National Medical Products Administration (NMPA) has approved the Phase III clinical trial application of …, (HKEX code: 1672) today announces that China National Medical Products Administration (NMPA) has approved the Phase III clinical trial application of …, Read More

Scroll to Top